$0.31
3.84% yesterday
Nasdaq, Apr 04, 10:00 pm CET
ISIN
US1897631057
Symbol
CODX
Sector
Industry

Co-Diagnostics, Inc. Stock price

$0.31
-0.18 36.27% 1M
-0.97 75.73% 6M
-0.44 58.59% YTD
-0.84 72.99% 1Y
-5.98 95.06% 3Y
-10.00 96.99% 5Y
-5.50 94.65% 10Y
Nasdaq, Closing price Fri, Apr 04 2025
-0.01 3.84%
ISIN
US1897631057
Symbol
CODX
Sector
Industry

Key metrics

Market capitalization $10.43m
Enterprise Value $-17.17m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 0.57
EV/Sales (TTM) EV/Sales -22.30
P/S ratio (TTM) P/S ratio 13.55
P/B ratio (TTM) P/B ratio 0.19
Revenue growth (TTM) Revenue growth -88.70%
Revenue (TTM) Revenue $770.00k
EBIT (operating result TTM) EBIT $-43.23m
Free Cash Flow (TTM) Free Cash Flow $-29.90m
Cash position $29.75m
EPS (TTM) EPS $-1.22
P/S forward 6.95
EV/Sales forward negative
Short interest 0.67%
Show more

Is Co-Diagnostics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Co-Diagnostics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Co-Diagnostics, Inc.:

1x Hold
100%

Analyst Opinions

1 Analyst has issued a forecast Co-Diagnostics, Inc.:

Hold
100%

Financial data from Co-Diagnostics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
0.77 0.77
89% 89%
100%
- Direct Costs 2.38 2.38
56% 56%
309%
-1.61 -1.61
215% 215%
-209%
- Selling and Administrative Expenses 19 19
3% 3%
2,501%
- Research and Development Expense 21 21
9% 9%
2,725%
-42 -42
1% 1%
-5,435%
- Depreciation and Amortization 1.38 1.38
10% 10%
179%
EBIT (Operating Income) EBIT -43 -43
1% 1%
-5,614%
Net Profit -38 -38
7% 7%
-4,888%

In millions USD.

Don't miss a Thing! We will send you all news about Co-Diagnostics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Co-Diagnostics, Inc. Stock News

Neutral
Seeking Alpha
8 days ago
Co-Diagnostics, Inc. (NASDAQ:CODX ) Q4 2024 Earnings Conference Call March 27, 2025 4:30 PM ET Company Participants Andrew Benson - IR Dwight Egan - CEO Brian Brown - CFO Conference Call Participants Operator Good day, and welcome to the Co-Diagnostics Fourth Quarter and Full Year 2024 Earnings Conference Call. All participants will be in a listen-only mode.
Neutral
PRNewsWire
8 days ago
SALT LAKE CITY , March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced financial results for the fourth quarter and full year ended December 31, 2024. Full Year 2024 Financial Results: Revenue of $3.9 million, which declined from $6.8 million during t...
Neutral
PRNewsWire
23 days ago
SALT LAKE CITY , March 13, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its fourth quarter and full year 2024 results on Thursday, March 27, 2025, after the market close. The Company will also host a conference call and webcast on the s...
More Co-Diagnostics, Inc. News

Company Profile

Co-Diagnostics, Inc. engages in the development, manufacture, and marketing of diagnostics technology. It offers design services, vector control, equipment, diagnostic, and research solutions. The company was founded by Brent C. Satterfield and Dwight H. Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.

Head office United States
CEO Dwight Egan
Employees 132
Founded 2013
Website www.codiagnostics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today